Previously mentioned studies on gastric cancer cells have identified potential mechanisms underlying SHP-2-induced oncogenic signaling through enhancement of RTK pathways, which is most likely how SHP-2 functions in breast cancer [11,78,79,80]. This evidence concerns the gene PTPN11 and breast carcinoma.